Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Inhibition of epileptiform activity by neuropeptide Y in brain tissue from drug-resistant temporal lobe epilepsy patients

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Simvastatin improves mitochondrial respiration in peripheral blood cells

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Development of a downstream process for the production of an inactivated whole hepatitis C virus vaccine

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Discrete finger sequences are widely represented in human striatum

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Author Correction: Assessment of brain reference genes for RT-qPCR studies in neurodegenerative diseases

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Identification of epilepsy-associated neuronal subtypes and gene expression underlying epileptogenesis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Aspects of cAMP Signaling in Epileptogenesis and Seizures and Its Potential as Drug Target

    Research output: Contribution to journalReviewResearchpeer-review

  3. Diagnostic added value of electrical source imaging in presurgical evaluation of patients with epilepsy: A prospective study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Genome-wide association study of panic disorder reveals genetic overlap with neuroticism and depression

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

In epilepsy patients, drug-resistant seizures often originate in one of the temporal lobes. In selected cases, when certain requirements are met, this area is surgically resected for therapeutic reasons. We kept the resected tissue slices alive in vitro for 48 h to create a platform for testing a novel treatment strategy based on neuropeptide Y (NPY) against drug-resistant epilepsy. We demonstrate that NPY exerts a significant inhibitory effect on epileptiform activity, recorded with whole-cell patch-clamp, in human hippocampal dentate gyrus. Application of NPY reduced overall number of paroxysmal depolarising shifts and action potentials. This effect was mediated by Y2 receptors, since application of selective Y2-receptor antagonist blocked the effect of NPY. This proof-of-concept finding is an important translational milestone for validating NPY-based gene therapy for targeting focal drug-resistant epilepsies, and increasing the prospects for positive outcome in potential clinical trials.

Original languageEnglish
JournalScientific Reports
Volume9
Issue number1
Pages (from-to)19393
ISSN2045-2322
DOIs
Publication statusPublished - 18 Dec 2019

ID: 58940603